Physician profile
Kenneth E Ruby
NPI 1063419133
$4,779.73
in general payments reported to CMS, 2019-2025
20 companies · $1,855 in 2025
The $1,855 reported for 2025 was more than what 78% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $391 · 2020: $369 · 2021: $112 · 2022: $1,172 · 2023: $529 · 2024: $351 · 2025: $1,855.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,522 · Travel and Lodging: $1,014 · Education: $199.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,522.35 |
| Travel and Lodging | $1,013.96 |
| Education | $198.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Procept Biorobotics Corporation | $1,226.64 | 2024-2025 | Aquabeam System |
| Medtronic, INC. | $1,163.15 | 2021-2023 | Interstim |
| Astellas Pharma US INC | $841.53 | 2019-2025 | Xtandi, Myrbetriq |
| Sumitomo Pharma America, INC. | $303.74 | 2023-2025 | Gemtesa, Orgovyx |
| Bayer Healthcare Pharmaceuticals INC. | $209.96 | 2023-2025 | |
| Janssen Biotech, INC. | $159.57 | 2019-2025 | Erleada |
| Pfizer INC. | $139.37 | 2019-2025 | |
| Endo USA, INC. | $128.27 | 2024-2025 | Xiaflex |
| Boston Scientific Corporation | $110.60 | 2019-2022 | |
| Endo Pharmaceuticals INC. | $98.28 | 2019-2023 | Xiaflex |
| Abbvie INC. | $74.68 | 2019-2025 | |
| Medtronic USA, INC. | $57.85 | 2019-2020 | |
| Olympus America INC. | $52.56 | 2023-2025 | Itind System, Oes Cystonephrofiberscope |
| Tolmar, INC. | $50.29 | 2024-2025 | Jatenzo |
| Coloplast Corp | $41.36 | 2019-2025 | Altis |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $39.22 | 2024-2025 | |
| Bioprotect Medical, INC. | $22.51 | 2025 | Bioprotect Balloon Implant System |
| Axonics, INC. | $22.17 | 2024 | Axonics |
| Blue Earth Diagnostics | $21.40 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $16.58 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kenneth Ruby listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.